In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance
Lu Shan et al. present a structure-guided approach to engineer a monovalent form of the fragment crystallizable (Fc) region of an IgG4 antibody to adapt multiple versions of half-life extension modifications and bispecific targeting. Additionally, they report co-crystal structures of the variants bo...
Guardado en:
Autores principales: | Lu Shan, Nydia Van Dyk, Nantaporn Haskins, Kimberly M. Cook, Kim L. Rosenthal, Ronit Mazor, Sonia Dragulin-Otto, Yu Jiang, Herren Wu, William F. Dall’Acqua, Martin J. Borrok, Melissa M. Damschroder, Vaheh Oganesyan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b758208695d4e46949303210404e03c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monovalent lanthanide(I) in borozene complexes
por: Wan-Lu Li, et al.
Publicado: (2021) -
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity
por: Ole A. Mandrup, et al.
Publicado: (2021) -
Agricultura, liquidez e recessão
por: Fernando Maida Dall'Acqua, et al.
Publicado: (1985) -
Long-lasting, monovalent-selective capacitive deionization electrodes
por: Eric N. Guyes, et al.
Publicado: (2021) -
CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014)